Trending...
- Arizona: Governor Katie Hobbs' Office Holds Border Community Listening Sessions
- Mesa Celebrates Valley Bike Month
- Mesa Summer Pool Passes are Now on Sale at Special Prices
FAIRFAX, Va., March 4, 2023 ~ A new study presented at the Society of Interventional Radiology Annual Scientific Meeting in Phoenix has found that a minimally invasive treatment, known as viable disc allograft supplementation, can provide significant improvement in pain and function for patients suffering from degenerative disc disease.
The treatment involves injecting specialized cells and fluid into a patient's damaged disc, encouraging the cells to regenerate with healthy tissue. Lead author Douglas Beall, M.D., FSIR, chief of radiology at Clinical Radiology of Oklahoma said: "The significant improvement in pain and function is promising for patients living with chronic low back pain – a condition that can greatly impact a person's quality of life. Back pain is the leading cause of limited activity and workplace absenteeism. This treatment may help patients return to a normal activity level for a longer period time."
The study involved fifty patients at nine sites, with 46 receiving allograft treatment and four receiving saline. The results showed that sixty percent of those who received allograft treatment reported a greater than 50% improvement in pain and 70% reported more than a 20-point improvement in their Oswestery Disability Index (ODI) scores. There were no persistent adverse events reported.
More on The Arizonar
Degenerative disc disease is the leading cause of chronic low back pain, which can lead to reduced functionality due to the discs cushioning the spine's vertebra wearing away. Beall said: "Existing treatment for chronic low back pain due to degenerative disc disease is often ineffective or the effects are short-lived. We need better treatments for this condition since conservative care is not providing the long-term outcomes that patients deserve. Injectable allograft treatment might be the answer for many people."
In addition to providing relief from chronic low back pain, use of allograft could even help decrease opioid use among patients with chronic low back pain, researchers said, which would be especially meaningful for younger patients who have years of function and quality of life to look forward to. The treatment requires no incisions and patients are able to go home on the same day. VIVIEX Biologics, Inc., who sponsored this study, also have Dr Beall as their medical consultant.
The results from this three-year voluntary extension trial suggest that viable disc allograft supplementation could be an effective way to provide relief from chronic low back pain associated with degenerative disc disease over a sustained period without any persistent adverse events being reported.
The treatment involves injecting specialized cells and fluid into a patient's damaged disc, encouraging the cells to regenerate with healthy tissue. Lead author Douglas Beall, M.D., FSIR, chief of radiology at Clinical Radiology of Oklahoma said: "The significant improvement in pain and function is promising for patients living with chronic low back pain – a condition that can greatly impact a person's quality of life. Back pain is the leading cause of limited activity and workplace absenteeism. This treatment may help patients return to a normal activity level for a longer period time."
The study involved fifty patients at nine sites, with 46 receiving allograft treatment and four receiving saline. The results showed that sixty percent of those who received allograft treatment reported a greater than 50% improvement in pain and 70% reported more than a 20-point improvement in their Oswestery Disability Index (ODI) scores. There were no persistent adverse events reported.
More on The Arizonar
- Databloom's Blossom Achieves Faster and More Efficient Big Data Analytics
- Elite Imagined High Net Worth Branding Online Reputation Management Expanding Into Malaysia Market
- Orchard Audio's New PecanPi®+ DAC and Streamer Feature AKM's Latest Flagship Chips
- Country Artist Ashley Wineland to Release Poignant Ballad 'I'm Going Home'; Announces Her 2023 National Tour
- Jennifer S. Wilkov Finalizes Lineup for the 2023 April Speak Up Women Conference
Degenerative disc disease is the leading cause of chronic low back pain, which can lead to reduced functionality due to the discs cushioning the spine's vertebra wearing away. Beall said: "Existing treatment for chronic low back pain due to degenerative disc disease is often ineffective or the effects are short-lived. We need better treatments for this condition since conservative care is not providing the long-term outcomes that patients deserve. Injectable allograft treatment might be the answer for many people."
In addition to providing relief from chronic low back pain, use of allograft could even help decrease opioid use among patients with chronic low back pain, researchers said, which would be especially meaningful for younger patients who have years of function and quality of life to look forward to. The treatment requires no incisions and patients are able to go home on the same day. VIVIEX Biologics, Inc., who sponsored this study, also have Dr Beall as their medical consultant.
The results from this three-year voluntary extension trial suggest that viable disc allograft supplementation could be an effective way to provide relief from chronic low back pain associated with degenerative disc disease over a sustained period without any persistent adverse events being reported.
Filed Under: Business
0 Comments
Latest on The Arizonar
- Sip Social Co. Partners With Apé Canada For Supply Of Piaggio Apé's
- Arizona Author's Title Tapped as One of Thirty Best
- U-Haul Promotes Kristine Campbell to Role of General Counsel
- Eddie Turner is Recognized as the #9 Motivational Speaker in the World By Global Gurus!
- Southern Arizona Sister Dude Ranches Place Top 5 in USA Today's 10Best Contest
- RE/MAX Signature Earns Top Regional Award
- Wohler releases out-of-band configuration tools for Riedel 2110 SFP's
- Levinger Regens Announces New Initiative to Improve Hydrogen Carbon Intensity
- Eve Wellness, a SF Breast Ultrasound Screening Clinic supports the recent FDA updates to the guidelines to inform women about breast density
- Expert tip: Private Jet Engine Maintenance Program - Pros and Cons for Preowned Jet Buyers
- Gaming and entertainment company Spinrack Corporation, appoints Jesse Norton as Chief Marketing Officer
- Arizona: Governor Hobbs' Nominees Reaffirm Their Qualifications to Lead Department of Public Safety and Department of Forestry and Fire Management In Senate Committee
- Mesa Celebrates Valley Bike Month
- Arizona: Governor Katie Hobbs' Office Holds Border Community Listening Sessions
- Mesa Summer Pool Passes are Now on Sale at Special Prices
- .Store Domains launches Elevate.store – a free-to-use platform for online sellers with deals on business tools
- Alliant International University Announces New Campus and School of Nursing & Health Sciences in Phoenix
- GP GLOBAL GROUP Secures $18M Sale of Shoppes at 41st Street Retail Plaza in Doral, Florida, with $11.5M CMBS Loan Assumption
- HLN's Immunization Calculation Engine (ICE) is continually updated to support new COVID-19 recommendations
- Rewilding Ireland with Lord Dunsany and IrishTrees